Skip to content

AMAG PHARMACEUTICALS, INC.

CIK 0000792977

← back to feed
Revenue (TTM)
$298.33M
+6.8% YoY Q3 Nov 2020
Net Income (TTM)
−$51.97M
−736.1% YoY Q3 Nov 2020
EPS Diluted (TTM)
−$5.14
−171.9% YoY Q3 Nov 2020
Gross Margin
15.5%
Q3 Nov 2020
Operating Margin
-14.5%
Q3 Nov 2020
Net Margin
-17.4%
Q3 Nov 2020
Free Cash Flow (TTM)
−$108.8M
Q3 Nov 2020
Cash
$97.98M
Q3 Nov 2020
Total Debt
$289.33M
Q3 Nov 2020
Shares Outstanding
34.73M sh
Q3 Nov 2020

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings